Vocxi is selected to present at the 2024 BLUE KNIGHT™ Symposium

SOURCE // Vocxi Health

< BACK TO NEWS

Vocxi Health is selected out of 400+ companies to present their poster at the 2024 BLUE KNIGHT™ Symposium. Blue Knight is a joint initiative between Johnson & Johnson and the Biomedical Advanced Research and Development Authority (BARDA).

Vocxi Health is selected out of 400+ companies to present their poster at the 2024 BLUE KNIGHT™ Symposium.

Blue Knight is a joint initiative between Johnson & Johnson and the Biomedical Advanced Research and Development Authority (BARDA) to anticipate health security threats, activate global innovation, and amplify technological advancements.
Vocxi’s diagnostic platform meets the critical criteria of global health preparedness by having characteristics of being a threat-agnostic platform, high accessibility, and immediate response. The event was held on June 2nd as a kick-off to BIO week.

We were honored to present our company poster at the event to help support national preparedness for threats against our country and its citizens.

< BACK TO NEWS & RESOURCES

Share the Post:

Related Posts

Vocxi is selected to present at the 2024 BLUE KNIGHT™ Symposium

June 17, 2024

Vocxi Health

Vocxi Health is selected out of 400+ companies to present their poster at the 2024 BLUE KNIGHT™ Symposium. Blue Knight is a joint initiative between Johnson & Johnson and the Biomedical Advanced Research and Development Authority (BARDA).

Vocxi wins pitch competition in Silicon Valley at Venture Summit West

May 17, 2024

Vocxi Health

Vocxi won the best pitch in the Healthcare/Tech Track out of dozens of leading global health technology companies at Venture Summit West.

Ramstad: Health care is a tough arena for AI to make a difference

April 24, 2024

Star Tribune

Executives from Twin Cities-based startup Vocxi Health described their device that will detect disease by sensing chemicals in a person's breath — specifically what they exhale. Its initial target market is patients suspected of having lung cancer.

Vocxi Health Prepares for Commercialization of Breath Test for Lung Cancer

March 26, 2024

360Dx

University of Minnesota spinout Vocxi Health is preparing to commercialize a point-of-care breath test for lung cancer that relies on highly sensitive biosensors and machine learning.

MedTech’s Next Gen

March 8, 2024

Twin Cities Business

Meet five Minnesota entrepreneurs taking big swings at health care innovation that could improve disease detection and treatment.

New lung cancer screening guidelines expand who should get tested annually

November 1, 2023

NBC News

"Only a fraction of people at high risk for lung cancer are getting screened for the disease even though it kills more in the United States than breast, colorectal and prostate cancers combined."